In the news

Applied Clinical Trials
20 June 2012

ePRO for Clinical Trials, Observational Studies and Registry Studies of Patients with Diabetes

This Autumn, prestigious industry publication Applied Clinical Trials will publish an informative article outlining the scientific and safety benefits of using ePRO (electronic patient reported outcome) Systems in Diabetes clinical research.

The article discusses how the use of ePRO data in clinical research is increasing as regulatory authorities acknowledge the credibility of such data, particularly in comparison to paper and pencil self-reports completed in unsupervised settings.

Readers will get an in-depth look at the case for converting from paper to ePRO for a PRO instrument designed to assess the impact of diabetes on the quality of life of patients with diabetes including:

  • Creating and validating the DHP-18 for EDC
  • Benefits of ePRO for Diabetes clinical trials collecting patient data
    validating the eDHP-18
  • DHP-18 and the eDHP-18 Instruments
  • Validation required to migrate from PRO to ePRO

For all press and media enquiries please contact media@dhpresearch.com